The value of PCR-reverse dot blot hybridization in detecting the drug resistance of Mycobacterium tuberculosis in sputum specimens of retreatment smear-positive pulmonary tuberculosis patients
LIU Zhi-bin, WU Min, WU Xiao-cui, HAN Min, XIAO He-ping, ZHANG Qing()
Department of Tuberculosis, Shanghai Pulmonary Hospital Affiliated to Tongji University School of Medicine, Shanghai 200433, China
LIU Zhi-bin, WU Min, WU Xiao-cui, HAN Min, XIAO He-ping, ZHANG Qing. The value of PCR-reverse dot blot hybridization in detecting the drug resistance of Mycobacterium tuberculosis in sputum specimens of retreatment smear-positive pulmonary tuberculosis patients[J]. Chinese Journal of Antituberculosis, 2021, 43(1): 47-51. doi: 10.3969/j.issn.1000-6621.2021.01.010
Pai M, Schito M. Tuberculosis diagnostics in 2015: landscape,priorities,needs, and prospects. J lnfect Dis, 2015, 2011 Suppl2:S21-28. doi: 10.1093/infdis/jiu803.
[6]
Denkinger CM, Kik SV, Cirillo DM, et al. Defining the needs for next generation assays for tuberculosis. J Infect Dis, 2015,211 Suppl2: S29-38. doi: 10.1093/infdis/jiu821.
doi: 10.1093/infdis/jiu821URL
[7]
中国防痨协会. 结核病实验室检验规程. .北京: 人民卫生出版社, 2015: 77-106.
[8]
World Health Organization. WHO consolidated guidelines on drug-resistant tuberculosis. Geneva: World Health Organization, 2019.